LexDanaLexDanabeta
Inventor

KENNER C. RICE

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
PatentTitleYear
12,472,248Antibodies against fentanyl and fentanyl analogs202511,939,297Cannabinoid receptor mediating compounds202411,485,709Cannabinoid receptor mediating compounds2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES (2)· patent assignee history
2022–2024Patents assigned to US HEALTH (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to THE US SECRETARY DEPARMENT OF HEALTH (1)· patent assignee history
2025Patents assigned to THE US SECRETARY DEPARTMENT OF HEALTH BETHESDA MD (1)· patent assignee history
2025Patents assigned to US GOV SEC ARMY (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES22022–2024
US HEALTH22022–2024
THE US SECRETARY DEPARMENT OF HEALTH12025
THE US SECRETARY DEPARTMENT OF HEALTH BETHESDA MD12025
US GOV SEC ARMY12025
Locations
LocationPatentsSpan
US32022–2025